Myriad Sues Again To Block Rival Gene-Based Cancer Test

Law360, New York (July 11, 2013, 3:07 PM EDT) -- Myriad Genetics Inc. on Wednesday filed a second patent infringement lawsuit in as many days over recently launched cancer-testing products, this time alleging that lower-cost genetic testing offered by Gene By Gene Ltd. infringes nine of its patents.

The lawsuit targets tests offered by DNATraits, a division of Gene By Gene, that look for genes and that increase a woman's risk of developing breast or ovarian cancer. The complaint was filed one day after Myriad sued Ambry Genetics Corp. for offering tests that also check for...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.